As we look toward 2026 and 2027, the value of in-person engagement is shifting...

https://highstylife.com/stop-chasing-hype-how-biotech-startups-should-actually-select-q1-conferences/

As we look toward 2026 and 2027, the value of in-person engagement is shifting from broad visibility to focused deal-making. Events like J.P. Morgan in San Francisco and ASCO in Chicago are critical for clinical and commercial alignment